Form 4: Vor Biopharma Inc. Executive Amy Quinlan Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Amy Quinlan, Vice President of Finance at Vor Biopharma Inc., reports the disposition of 206 shares of common stock to cover tax obligations related to restricted stock units.
Summary
- On November 6, 2024, Amy Quinlan, the Vice President of Finance at Vor Biopharma Inc., disposed of 206 shares of common stock.
- The shares were withheld to satisfy tax obligations related to the settlement of restricted stock units.
- Following the transaction, Quinlan directly owns 50,312 shares of Vor Biopharma Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard tax obligations, and does not indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations on vested equity.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Date of stock transaction where 206 shares were disposed of to cover tax obligations. |
| 11/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.